Combination Therapy Seen to Slow Further Spread of Metastatic Breast Cancer in …

Combination Therapy Seen to Slow Further Spread of Metastatic Breast Cancer in …

Primary findings showed that neratinib plus paclitaxel was not superior to trastuzumab plus paclitaxel as first-line treatment for ERBB2-positive metastatic breast cancer in terms of progression-free survival, but the combination was associated with

(Visited 2 times, 1 visits today)
4
Like
Save

Comments

Write a comment